Evaluation of the ARCHITECT urine NGAL assay: Assay performance, specimen handling requirements and biological variability

Clinical Biochemistry

Volumn 43, Issue 6, 2010, Pages 615-620

  Grenier, Frank C ^a   Ali, Salman ^a   Syed, Hina ^a   Workman, Ryan ^a   Martens, Frans ^b   Liao, Ming ^c   Wang, Y ^c   Wong, Pui Yuen ^c  

^a ABBOTT LABORATORIES   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Acute Kidney Injury; Architect; Immunoassay; NGAL

Indexed keywords

BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ANALYZER; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; KIDNEY INJURY; LABORATORY DIAGNOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DETERMINATION; RELIABILITY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; STORAGE TEMPERATURE; THERMOSTABILITY; URINALYSIS;

ACUTE-PHASE PROTEINS; ADULT; BIOLOGICAL MARKERS; CHILD; DRUG INCOMPATIBILITY; EFFICIENCY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY FAILURE, ACUTE; LIPOCALINS; OBSERVER VARIATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; URINALYSIS;

EID: 77950858129     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.12.008     Document Type: Article

References (32)

1. Venge P., Carlson M., Fredens K., Garcia R. The 40-kD protein. A new protein isolated from the secondary granules of human neutrophils. J. Leukoc. Biol. 1990, Suppl 1:28.
2. Allen R.A., Erickson R.W., Jesaitis A.J. Identification of a human neutrophil protein of Mr 24 000 that binds N-formyl peptides: co-sedimentation with specific granules. Biochim. Biophys. Acta (BBA)-Gen. Subj. 1989, 991:123-133.
3. Kjeldsen L., Johnsen A., Sengelov H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 1993, 268:10425-10432.
4. Coles M., Diercks T., Muehlenweg B., et al. The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin. J. Mol. Biol. 1999, 289:139-157.
5. Goetz D.H., Willie S.T., Armen R.S., Bratt T., Borregaard N., Strong R.K. Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 2000, 39:1935-1941.
6. Strong R.K., Bratt T., Cowland J.B., Borregaard N., Wiberg F.C., Ewald A.J. Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL). Acta Crystallogr. 1998, D54:93-95.
7. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 2002, 10:1033-1043.
8. Yang J., Goetz D., Li J.Y., et al. An iron delivery pathway mediated by a lipocalin. Mol. Cell 2002, 10:1045-1056.
9. Xu S.Y., Pauksen K., Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand. J. Clin. Lab. Invest. 1995, 55:125-131.
10. Chertow G.M., Burdick E., Honour M., Bonventre J.V., Bates D.W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 2005, 16:3365-3370.
11. Star R.A. Treatment of acute renal failure. Kidney Int. 1998, 54:1817-1831.
12. Mishra J., Ma Q., Prada A., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 2003, 14:2534-2543.
13. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
14. Bennett M., Dent C.L., Ma Q., et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin. J. Am. Soc. Nephrol. 2008, 3:665-673.
15. Nickolas T.L.M.D.M.S., O'Rourke M.J.B.S., Yang J.M.D.P., et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann. Intern. Med. 2008, 148:810-819.
16. Parikh C.R., AJ J., Mishra Q., Ma C., Kelly J., Barasch C.L., Edelstein P. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am. J. Transplant. 2006, 6:1639-1645.
17. Wang Y., Lam K.S.L., Kraegen E.W., et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin. Chem. 2007, 53:34-41.
18. van Dam R.M., Hu F.B. Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2?. Clin. Chem. 2007, 53:5-7.
19. D'Anna R., Baviera G., Giordano D., Todarello G., Corrado F., Buemi M. Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. Acta Obstet. Gynecol. Scand. 2008, 87:1370-1373.
20. Coca S.G., Yalavarthy R., Concato J., Parikh C.R. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2007, 73:1008-1016.
21. Waikar S.S., Liu K.D., Chertow G.M. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin. J. Am. Soc. Nephrol. 2008, 3:844-861.
22. Devarajan P. Neutrophil gelatinase-associated lipocalin-an emerging troponin for kidney injury. Nephrol. Dial. Transplant. 2008, 23:3737-3743.
23. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 2009, 54:1012-1024.
24. Vaidya V.S., Ferguson M.A., Bonventre J.V. Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 2008, 48:463-493.
25. NCCLS, Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline-Second Edition. NCCLS document EP5-A2 [ISBN 1-56238-542-9]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2004.
26. Kjeldsen L., Cowland J.B., Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta (BBA)- Protein Struct. Mol. Enzymol. 2000, 1482:272-283.
27. Haase-Fielitz A., Haase M., Bellomo R. Instability of urinary NGAL during long-term storage. Am. J. Kidney Dis. 2009, 53:564-565. author reply.
28. Bolignano D., Lacquaniti A., Coppolino G., et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2009, 4:337-344.
29. Ichino M., Kuroyanagi Y., Kusaka M., et al. Increased urinary neutrophil gelatinase associated lipocalin levels in a rat model of upper urinary tract infection. J. Urol. 2009, 181:2326-2331.
30. Yilmaz A., Sevketoglu E., Gedikbasi A., et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr. Nephrol. 2009, 24:2387-2392.
31. Pepe M.S., Etzioni R., Feng Z., et al. Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst. 2001, 93:1054-1061.
32. Pepe M.S., Feng Z., Janes H., Bossuyt P.M., Potter J.D. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J. Natl. Cancer Inst. 2008, 100:1432-1438.